Arcturus Therapeutics
ARCT
#8533
Rank
โ‚น21.53 B
Marketcap
โ‚น757.75
Share price
3.39%
Change (1 day)
-24.92%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -โ‚น6.48 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are โ‚น85.14 Million. In 2024 the company made an earning of -โ‚น8.83 Billion a decrease over its 2023 earnings that were of -โ‚น2.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น6.48 Billion-26.66%
2024 -โ‚น8.83 Billion240.24%
2023 -โ‚น2.6 Billion-298.78%
2022 โ‚น1.30 B-106.79%
2021 -โ‚น19.24 Billion181.83%
2020 -โ‚น6.83 Billion183.72%
2019 -โ‚น2.41 Billion16.93%
2018 -โ‚น2.06 Billion154.5%
2017 -โ‚น0.81 Billion-65.36%
2016 -โ‚น2.34 Billion25.93%
2015 -โ‚น1.86 Billion-41.04%
2014 -โ‚น3.15 Billion219.64%
2013 -โ‚น0.99 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-97.12% Bahamas
NRC Health
NRC
โ‚น2.63 B-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA